Home / Hepatitis B Immunoglobulin / Belgium
BE ATC J06BB04 · updated 2 Nov 2026
Hepatitis B Immunoglobulin shortage in Belgium
Is there a Hepatitis B Immunoglobulin shortage in Belgium?
Yes. As of 2 Nov 2026, 1 Hepatitis B Immunoglobulin product is reported short in Belgium, the first since 1 Apr 2025. The company estimate for the return is 15 Mar 2027. Main reason: manufacturing problem.
Also short in Italy. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Hepacaf 5 000 IU inf. sol. (pwdr. + solv.) i.v. 5000 IU + 100 ml | LFB BIOMEDICAMENTS | 1 Apr 2025 | 15 Mar 2027 | Manufacturing problem Delay in production |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.